Overview

The Effectiveness and Safety of Levosimendan in Patients With Severe Aortic Stenosis and Heart Failure Undergoing Transcatheter Aortic Valve Replacement

Status:
Recruiting

Trial end date:
2022-12-30

Target enrollment:

Participant gender:

Summary

A study to evaluate the effectiveness and safety of levosimendan compared with placebo in subjects with severe aortic stenosis and heart failure undergoing transcatheter aortic valve replacement

Phase:

Phase 4

Details

Lead Sponsor:

China National Center for Cardiovascular Diseases

Collaborator:

China International Medical Foundation

Treatments:

Simendan